440 related articles for article (PubMed ID: 24180403)
1. Population based Helicobacter pylori screening and eradication: advances versus side effects.
Tepes B
Curr Pharm Des; 2014; 20(28):4501-9. PubMed ID: 24180403
[TBL] [Abstract][Full Text] [Related]
2. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
3. Identification of a high risk gastric cancer group using serum pepsinogen after successful eradication of Helicobacter pylori.
Haneda M; Kato M; Ishigaki S; Suzuki M; Takahashi M; Nakagawa M; Ono S; Mori Y; Mabe K; Nakagawa S; Kudo T; Shimizu Y; Asaka M
J Gastroenterol Hepatol; 2013 Jan; 28(1):78-83. PubMed ID: 23034090
[TBL] [Abstract][Full Text] [Related]
4. Long-term dynamics of gastric biomarkers after eradication of Helicobacter pylori infection.
Daugule I; Ruskule A; Moisejevs G; Rudzite D; Jonaitis L; Janciauskas D; Kiudelis G; Kupcinskas L; Leja M
Eur J Gastroenterol Hepatol; 2015 May; 27(5):501-5. PubMed ID: 25822857
[TBL] [Abstract][Full Text] [Related]
5. [The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer].
Adamczyk M; Peczek Ł; Rudnicki C; Nawrot B; Stec-Michalska K
Pol Merkur Lekarski; 2013 Sep; 35(207):141-7. PubMed ID: 24224450
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection.
Kwon Y; Jeon S; Nam S; Shin I
Aliment Pharmacol Ther; 2017 Oct; 46(8):758-767. PubMed ID: 28799258
[TBL] [Abstract][Full Text] [Related]
7. Optimized diagnosis of
Cho JH; Jin SY
Expert Rev Gastroenterol Hepatol; 2020 Jul; 14(7):553-564. PubMed ID: 32410515
[TBL] [Abstract][Full Text] [Related]
8. Screening and eradication of
Liou JM; Malfertheiner P; Lee YC; Sheu BS; Sugano K; Cheng HC; Yeoh KG; Hsu PI; Goh KL; Mahachai V; Gotoda T; Chang WL; Chen MJ; Chiang TH; Chen CC; Wu CY; Leow AH; Wu JY; Wu DC; Hong TC; Lu H; Yamaoka Y; Megraud F; Chan FKL; Sung JJ; Lin JT; Graham DY; Wu MS; El-Omar EM;
Gut; 2020 Dec; 69(12):2093-2112. PubMed ID: 33004546
[TBL] [Abstract][Full Text] [Related]
9. [Helicobacter pylori-related diseases].
Gisbert JP
Gastroenterol Hepatol; 2013 Oct; 36 Suppl 2():39-50. PubMed ID: 24160951
[TBL] [Abstract][Full Text] [Related]
10. HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE.
Coelho MCF; Ribeiro HG; Gomes CGO; Marinho FP; Barbosa AJA; Coelho LGV
Arq Gastroenterol; 2021; 58(1):39-47. PubMed ID: 33909795
[TBL] [Abstract][Full Text] [Related]
11. [Could Helicobacter pylori treatment reduce stomach cancer risk?].
Bretagne JF
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):440-52. PubMed ID: 12700501
[TBL] [Abstract][Full Text] [Related]
12. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels.
Yanaoka K; Oka M; Ohata H; Yoshimura N; Deguchi H; Mukoubayashi C; Enomoto S; Inoue I; Iguchi M; Maekita T; Ueda K; Utsunomiya H; Tamai H; Fujishiro M; Iwane M; Takeshita T; Mohara O; Ichinose M
Int J Cancer; 2009 Dec; 125(11):2697-703. PubMed ID: 19610064
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS;
JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144
[TBL] [Abstract][Full Text] [Related]
14. Multicentric randomised study of
Leja M; Park JY; Murillo R; Liepniece-Karele I; Isajevs S; Kikuste I; Rudzite D; Krike P; Parshutin S; Polaka I; Kirsners A; Santare D; Folkmanis V; Daugule I; Plummer M; Herrero R
BMJ Open; 2017 Aug; 7(8):e016999. PubMed ID: 28801429
[TBL] [Abstract][Full Text] [Related]
15. Metachronous gastric cancer after successful Helicobacter pylori eradication.
Shiotani A; Haruma K; Graham DY
World J Gastroenterol; 2014 Sep; 20(33):11552-9. PubMed ID: 25206262
[TBL] [Abstract][Full Text] [Related]
16. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.
Hansen S; Vollset SE; Derakhshan MH; Fyfe V; Melby KK; Aase S; Jellum E; McColl KE
Gut; 2007 Jul; 56(7):918-25. PubMed ID: 17317788
[TBL] [Abstract][Full Text] [Related]
17. Can gastric cancer be prevented?
Tepes B
J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():71-7. PubMed ID: 20388948
[TBL] [Abstract][Full Text] [Related]
18. Severe gastritis decreases success rate of Helicobacter pylori eradication.
Kalkan IH; Sapmaz F; Güliter S; Atasoy P
Wien Klin Wochenschr; 2016 May; 128(9-10):329-34. PubMed ID: 26637331
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori infection, serum pepsinogens, and pediatric abdominal pain: a pilot study.
Kassem E; Naamna M; Mawassy K; Beer-Davidson G; Muhsen K
Eur J Pediatr; 2017 Aug; 176(8):1099-1105. PubMed ID: 28681188
[TBL] [Abstract][Full Text] [Related]
20. Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm.
Choi HS; Lee SY; Kim JH; Sung IK; Park HS; Shim CS; Jin CJ
J Dig Dis; 2014 Jun; 15(6):293-8. PubMed ID: 24602176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
